Latest data shows the largest indicative borrow rate increases among liquid option names include: BioXcel Therapeutics (BTAI) 108.41% +5.45, Spring Valley Acquisition Corp (SMR) 495.12% +3.85, Innoviz (INVZ) 3.86% +1.05, iShares Nasdaq Biotechnology Index Fund (IBB) 1.58% +0.85, Microvision (MVIS) 12.48% +0.67, Gold Fields (GFI) 2.45% +0.47, VinFast Auto LTD (VFS) 130.07% +0.36, PureCycle Technologies (PCT) 27.98% +0.36, Nikola (NKLA) 8.67% +0.33, and Canadian Natural (CNQ) 0.72% +0.24.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BTAI:
- BioXcel Therapeutics Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
- BioXcel Therapeutics price target lowered to $7 from $18 at Canaccord
- BioXcel Therapeutics price target lowered to $7 from $8 at BofA
- Options Volatility and Implied Earnings Moves Today, March 12, 2024
- BioXcel Therapeutics provides updates on clinical programs for BXCL501
